Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Koussa

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
European Journal of Haematology|April 25, 2000
Beta-thalassaemia intermedia in LebanonM Qatanani, A Taher, S Koussa, et al.
European Journal of Haematology|July 20, 2000
Relation of ferritin levels to pulmonary function in patients with thalassemia major and the acute effects of transfusionN Kanj, A Shamseddine, W Gharzeddine, et al.
Acta Haematologica|August 7, 1999
Efficacy and side effects of deferiprone (L1) in thalassemia patients not compliant with desferrioxamineA Taher, F M Chamoun, S Koussa, et al.
American Journal of Human Genetics|June 10, 2000
Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate geneV Delague, C Bareil, S Tuffery, et al.
Acta Haematologica|November 27, 2004
Five-year trial of deferiprone chelation therapy in thalassaemia major patientsA Taher, E Aoun, A I Sharara, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 17, 2022
Impact on quality of life in multiple sclerosis patients: Which urinary symptoms are to blame?T Ziadeh, G Mjaess, J El Helou, et al.
Revue Neurologique|February 26, 2013
LSN MS guidelines for the management of multiple sclerosisA R Shatila, S Koussa, R Jabbour, et al.
Current Medical Research and Opinion|May 7, 2015
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS)B Yamout, R Alroughani, M Al-Jumah, et al.
Multiple Sclerosis and Related Disorders|November 1, 2019
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelinesB Yamout, M Sahraian, S Bohlega, et al.
Multiple Sclerosis and Related Disorders|January 21, 2024
Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelinesB Yamout, M Al-Jumah, M A Sahraian, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Journal of Haematology|April 25, 2000
Beta-thalassaemia intermedia in LebanonM Qatanani, A Taher, S Koussa, et al.
European Journal of Haematology|July 20, 2000
Relation of ferritin levels to pulmonary function in patients with thalassemia major and the acute effects of transfusionN Kanj, A Shamseddine, W Gharzeddine, et al.
Acta Haematologica|August 7, 1999
Efficacy and side effects of deferiprone (L1) in thalassemia patients not compliant with desferrioxamineA Taher, F M Chamoun, S Koussa, et al.
American Journal of Human Genetics|June 10, 2000
Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate geneV Delague, C Bareil, S Tuffery, et al.
Acta Haematologica|November 27, 2004
Five-year trial of deferiprone chelation therapy in thalassaemia major patientsA Taher, E Aoun, A I Sharara, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 17, 2022
Impact on quality of life in multiple sclerosis patients: Which urinary symptoms are to blame?T Ziadeh, G Mjaess, J El Helou, et al.
Revue Neurologique|February 26, 2013
LSN MS guidelines for the management of multiple sclerosisA R Shatila, S Koussa, R Jabbour, et al.
Current Medical Research and Opinion|May 7, 2015
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS)B Yamout, R Alroughani, M Al-Jumah, et al.
Multiple Sclerosis and Related Disorders|November 1, 2019
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelinesB Yamout, M Sahraian, S Bohlega, et al.
Multiple Sclerosis and Related Disorders|January 21, 2024
Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelinesB Yamout, M Al-Jumah, M A Sahraian, et al.
Pageof 4